Golimumab Clinical Trials
3 recruitingDrug
Phase 32
Showing 1–3 of 3 trials
Recruiting
Phase 3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Rheumatoid Arthritis
University of Nebraska400 enrolled1 locationNCT03414502
Recruiting
Phase 3
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Psoriatic Arthritis
University of Pennsylvania63 enrolled14 locationsNCT05669833
Recruiting
CHronic Nonbacterial Osteomyelitis International Registry
Chronic Recurrent Multifocal OsteomyelitisChronic Nonbacterial Osteomyelitis
Seattle Children's Hospital2,000 enrolled1 locationNCT04725422